Skip to Main Content

Paper Details

The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors.
Journal of Immunotherapy
1
2023
Solid Tumors, T-cell immunoglobulin and mucin domain 3, TIM3, myxoma, myxoma virus, tumor

Datasets

Release 1.2